SCHEMBL6333334

SCHEMBL6333334

COc1cc2c(cc1C=O)CCCC2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
KDM4E B2RXH2 1/20 0.59
TSHR P16473 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
MAPT P10636 2/20 0.51
LMNA P02545 1/20 0.51
HPGD P15428 1/20 0.51
GAA P10253 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PDE4D Q08499 1/20 0.45
PRKDC P78527 1/20 0.44
SLC2A1 P11166 1/20 0.43
NPC1 O15118 1/20 0.43
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.43
POLA1 P09884 2/20 0.42
NOD2 Q9HC29 1/20 0.41
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23090404 0.98 ALDH1A1 (0.57) ALDH1A1KDM4ETSHRTDP1MAPT
SCHEMBL6333760 0.96 ALDH1A1 (0.59) ALDH1A1KDM4ETSHRTDP1MAPT
SCHEMBL22953905 0.84 ALDH1A1 (0.63) ALDH1A1KDM4ETSHRTDP1MAPT
SCHEMBL8121645 0.81 ALDH1A1 (0.40) ALDH1A1KDM4ETSHRTDP1MAPT
SCHEMBL14925185 0.80 HTR2A (0.49) ALDH1A1KDM4ETSHRTDP1MAPT
SCHEMBL14925143 0.80 HTR2A (0.49) ALDH1A1KDM4ETSHRTDP1MAPT
SCHEMBL59900 0.79 MAPT (0.62) ALDH1A1KDM4EMAPTGAASMN1; SMN2
SCHEMBL3136850 0.79 ALDH1A1 (0.90) ALDH1A1KDM4ETSHRTDP1MAPT
SCHEMBL10600748 0.79 LMNA (0.58) ALDH1A1KDM4ETSHRTDP1MAPT
SCHEMBL18122545 0.79 ALDH1A1 (0.47) ALDH1A1KDM4ETSHRTDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2663542-B1 PROCESS FOR THE PREPARATION OF ALDITOL ACETALS RELIANCE IND LTD (IN) 2016-07-06 EP claimed
US-9029575-B2 Process for preparation of acetals RELIANCE INDUSTRIES LIMITED (IN) 2015-05-12 US claimed
US-8969595-B2 Method of making diacetal compound in aqueous medium RELIANCE INDUSTRIES LIMITED (IN) 2015-03-03 US claimed
US-8871954-B2 Process for the preparation of alditol acetals RELIANCE INDUSTRIES LIMITED (IN) 2014-10-28 US claimed
EP-2663569-A1 PROCESS FOR PREPARING ALDITOL ACETALS Reliance Industries Limited (IN) 2013-11-20 EP claimed
EP-2663542-A1 PROCESS FOR THE PREPARATION OF ALDITOL ACETALS Reliance Industries Limited (IN) 2013-11-20 EP claimed
EP-2663568-A1 PROCESS FOR PREPARATION OF ACETALS Reliance Industries Limited (IN) 2013-11-20 EP claimed
EP-2663541-A1 METHOD OF MAKING DIACETAL COMPOUND IN AQUEOUS MEDIUM Reliance Industries Limited (IN) 2013-11-20 EP claimed
US-20130303787-A1 Process For Preparing Alditol Acetals RELIANCE INDUSTRIES LIMITED (IN) 2013-11-14 US claimed
US-20130296580-A1 Process For Preparation Of Acetals RELIANCE INDUSTRIES LIMITED (IN) 2013-11-07 US claimed
US-20130296581-A1 Process For The Preparation of Alditol Acetals RELIANCE INDUSTRIES LIMITED (IN) 2013-11-07 US claimed
US-20130281716-A1 METHOD OF MAKING DIACETAL COMPOUND IN AQUEOUS MEDIUM RELIANCE INDUSTRIES LIMITED (IN) 2013-10-24 US claimed
WO-2012095856-A1 PROCESS FOR PREPARING ALDITOL ACETALS RELIANCE INDUSTRIES LTD. (IN) 2012-07-19 WO claimed
WO-2012095857-A1 METHOD OF MAKING DIACETAL COMPOUND IN AQUEOUS MEDIUM RELIANCE INDUSTRIES LTD. (IN) 2012-07-19 WO claimed
WO-2012095858-A1 PROCESS FOR THE PREPARATION OF ALDITOL ACETALS RELIANCE INDUSTRIES LTD., (IN) 2012-07-19 WO claimed
WO-2012095855-A1 PROCESS FOR PREPARATION OF ACETALS RELIANCE INDUSTRIES LTD., (IN) 2012-07-19 WO claimed
US-11839613-B2 Pyrimidine derivatives as PGE2 receptor modulators IDORSIA PHARMACEUTICALS LTD (CH) 2023-12-12 US disclosed
EP-3625228-B1 PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2021-07-07 EP disclosed
EP-1349834-A2 CYCLOALKYFUSED [G]-INDOLE COMPOUNDS AS SPLA2-INHIBITORS IN THE TREATMENT OF INFLAMMATORY DISEASES ELI LILLY AND COMPANY (US) 2003-10-08 EP disclosed
WO-2002050030-A2 CYCLOALKYLFUSED [G]-INDOLE COMPOUNDS AS SPLA2-INHIBITORS IN THE TREATMENT OF INFLAMMATORY DISEASES ELI LILLY AND COMPANY (US) 2002-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11839613-B2 Pyrimidine derivatives as PGE2 receptor modulators PTGER1, PTGER4, PTGER2 ALDH1A1 468/4885KDM4E 1571/4885TSHR 654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.